Exact Sciences Files 8-K on Shareholder Votes and Financials
Ticker: EXAS · Form: 8-K · Filed: Jun 17, 2024 · CIK: 1124140
| Field | Detail |
|---|---|
| Company | Exact Sciences CORP (EXAS) |
| Form Type | 8-K |
| Filed Date | Jun 17, 2024 |
| Risk Level | low |
| Pages | 2 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.01 |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, financial-reporting, sec-filing
Related Tickers: EXAS
TL;DR
EXAS filed an 8-K on June 13th covering shareholder votes and financials.
AI Summary
Exact Sciences Corporation filed an 8-K on June 17, 2024, reporting on matters submitted to a vote of security holders and financial statements as of June 13, 2024. The filing details routine corporate actions and disclosures.
Why It Matters
This filing provides transparency into Exact Sciences Corporation's corporate governance and financial reporting, which is crucial for investors to assess the company's operational status and decision-making processes.
Risk Assessment
Risk Level: low — This is a routine 8-K filing for corporate disclosures and does not indicate any unusual or significant events.
Key Numbers
- 001-35092 — SEC File Number (Identifies the company's filing history with the SEC.)
- 02-0478229 — IRS Employer Identification No. (Tax identification number for the company.)
Key Players & Entities
- EXACT SCIENCES CORP (company) — Filer
- 0001124140-24-000054 (document_id) — Accession Number
- June 13, 2024 (date) — Earliest event reported
- June 17, 2024 (date) — Filing Date
- 5505 Endeavor Lane Madison, WI 53719 (address) — Principal Executive Offices
FAQ
What specific matters were submitted to a vote of security holders?
The filing indicates 'Submission of Matters to a Vote of Security Holders' as an item, but the specific details of these matters are not elaborated in the provided text.
What financial statements are included in this filing?
The filing states 'Financial Statements and Exhibits' are included, but the specific financial statements are not detailed in the provided excerpt.
What is the principal executive office address of Exact Sciences Corporation?
The principal executive offices are located at 5505 Endeavor Lane, Madison, WI 53719.
When was the earliest event reported in this 8-K filing?
The earliest event reported is dated June 13, 2024.
What is the SIC code for Exact Sciences Corporation?
The Standard Industrial Classification (SIC) code for Exact Sciences Corporation is 8071, which corresponds to Medical Laboratories.
Filing Stats: 588 words · 2 min read · ~2 pages · Grade level 13.7 · Accepted 2024-06-17 07:00:43
Key Financial Figures
- $0.01 — ange on which registered Common Stock, $0.01 par value per share EXAS The Nasdaq Sto
Filing Documents
- exas-20240613.htm (8-K) — 44KB
- 0001124140-24-000054.txt ( ) — 168KB
- exas-20240613.xsd (EX-101.SCH) — 2KB
- exas-20240613_lab.xml (EX-101.LAB) — 22KB
- exas-20240613_pre.xml (EX-101.PRE) — 13KB
- exas-20240613_htm.xml (XML) — 3KB
07. Submission of Matters to a Vote of Security Holders
Item 5.07. Submission of Matters to a Vote of Security Holders. On June 13, 2024, Exact Sciences Corporation (the "Company") held its 2024 Annual Meeting of Shareholders (the "2024 Annual Meeting"). The certified results of the matters voted upon at the 2024 Annual Meeting, which are more fully described in the Proxy Statement for the 2024 Annual Meeting as filed with the Securities and Exchange Commission on April 25, 2024, are as follows: The Company's shareholders elected the three nominees to the Company's Board of Directors to serve for one-year terms as Class III directors, with the votes cast as follows: Director Name For Against Abstain Broker Non-Votes Michael Barber 142,793,585 1,061,255 105,667 19,803,304 Paul Clancy 139,186,510 4,681,316 92,681 19,803,304 Daniel Levangie 138,989,098 4,875,822 95,587 19,803,304 The Company's shareholders ratified the appointment of PricewaterhouseCoopers, LLP as the Company's independent registered public accounting firm for 2024, with votes cast as follows: For Against Abstain 163,094,605 440,055 229,151 The Company's shareholders approved, on an advisory basis, the compensation paid to the Company's named executive officers, with votes cast as follows: For Against Abstain Broker Non-Votes 131,505,677 12,170,551 284,279 19,803,304
01. Financial Statements and Exhibits
Item 9.01. Financial Statements and Exhibits. Exhibits The exhibits required to be filed as a part of this Current Report on Form 8-K are listed below and incorporated herein by reference: Exhibit No. Exhibit Description 104 The cover page from this Current Report on Form 8-K, formatted in Inline XBRL 2
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. EXACT SCIENCES CORPORATION Date: June 17, 2024 By: /s/ Aaron Bloomer Aaron Bloomer Executive Vice President and Chief Financial Officer 3